Navigation Links
New Web Sites Educate About Triglycerides and HDL Cholesterol
Date:11/12/2009

ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Nearly one in three adult Americans have triglyceride (trig) levels that are above normal and nearly 34 million have low HDL "good" cholesterol levels. To help increase awareness about the importance of HDL and trigs, Abbott has launched two Web sites: www.knowyourhdl.com and www.knowyourtrigs.com.

"Unhealthy high triglyceride and low HDL levels are factors that can raise the risk of heart disease," said Eliot A. Brinton, M.D., associate professor, University of Utah, School of Medicine. "Understanding cholesterol and lipids, fats found in the blood, can be confusing, but it's important patients know what HDL and triglycerides are and how they can affect heart health."

Often, cholesterol conversations center on LDL, the "bad" cholesterol. These Web sites focus on commonly overlooked HDL and trigs and the role they play in health. Other information featured includes tips on diet, exercise and how patients can talk to their doctor about their risk factors for heart disease.

"Abbott has a long-standing commitment to patient education and providing tools patients need to take a proactive approach to managing their health," said Darryl Sleep, M.D., Dyslipidemia project director, Abbott. "These new Web sites encourage education, a healthy lifestyle and communication with physicians to help patients better understand important heart disease risk factors."

About HDL Cholesterol

There are two sources of HDL cholesterol: the liver and food. According to the American Heart Association, a low level of HDL cholesterol (less than 40 mg/dL for men and less than 50 mg/dL for women) may increase the risk of developing heart disease. However, a high level of HDL cholesterol (60 mg/dL or more) may protect against heart disease.

About Triglycerides

Triglycerides are lipids, fats found in the blood, made by the body and found in food. In normal amounts (less than 150 mg/dL), triglycerides help provide energy and are important to one's health. However, high amounts of triglycerides (200 mg/dL or more) can contribute to the hardening and narrowing of blood vessels, making it hard for blood to flow and increasing the risk for heart disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
3. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
4. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
5. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
6. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
7. Parasites That Live Inside Cells Use Loophole to Thwart Immune System
8. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
9. CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
10. Radius Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
11. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):